> ## Content Index
> Fetch the complete content index at: https://www.huntingalphas.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pfizer: 3 Key Risks That Warrant A Sell (Archive)
- URL: https://www.huntingalphas.com/pfizer-3-key-risks-that-warrant-a-sell-archive/
- Published: 2025-02-12T11:04:00.000Z
- Updated: 2026-02-28T14:36:17.000Z
- Description: Patent cliffs, weak margins, and bearish technicals justify maintaining a Sell stance.
- Author: Vish (Hunting Alphas)
- Tags: 5-Minute Pitches, #noindex, Archive, #sa-origin, PFE, Healthcare

*This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.*

## Elevator Pitch

- Pfizer's business is facing material revenue shrink issues due to many patent expirations over the next 3 years. Quarterly revenue run rate analysis suggests management may be underestimating the impact.
- PFE continues to have recurring 'unusual charges.' Accounting for this, its EBIT margins are in barely profitable territory.
- The Company is trading at a 32% 1-yr fwd PE discount to peers, but I think this is deserved given its revenue and profitability challenges.
- Relative technicals vs. the S&P 500 look bearish, having recently made a new lower low in the ratio charts.
- Blockbuster drug launches are an upside risk. But I think management's optimism here may be overestimated, as they have grossly overestimated drugs' commercialization potentials before.

Read the full article [here](https://seekingalpha.com/article/4757302-pfizer-3-key-risks-that-warrant-a-sell?ref=huntingalphas.com).

#### Disclosures and Disclaimers

**Past performance ≠ future results. Not investment advice. See* [**full Disclaimer*](https://www.huntingalphas.com/disclaimer/)**.*